Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Allison A. C., Denman A. M., Barnes R. D. Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity. Lancet. 1971 Jul 17;2(7716):135–140. doi: 10.1016/s0140-6736(71)92306-3. [DOI] [PubMed] [Google Scholar]
- Amos H. E., Brigden W. D., McKerron R. A. Untoward effects associated with practolol: demonstration of antibody binding to epithelial tissue. Br Med J. 1975 Mar 15;1(5958):598–600. doi: 10.1136/bmj.1.5958.598. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brown P., Baddeley H., Read A. E., Davies J. D., McGarry J. Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol). Lancet. 1974 Dec 21;2(7895):1477–1481. doi: 10.1016/s0140-6736(74)90218-9. [DOI] [PubMed] [Google Scholar]
- Felix R. H., Comaish J. S. The value of patch and other skin tests in drug eruptions. Lancet. 1974 May 25;1(7865):1017–1019. doi: 10.1016/s0140-6736(74)90417-6. [DOI] [PubMed] [Google Scholar]
- Felix R. H., Ive F. A., Dahl M. G. Cutaneous and ocular reactions to practolol. Br Med J. 1974 Nov 9;4(5940):321–324. doi: 10.1136/bmj.4.5940.321. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hughes G. R. Significance of anti-D.N.A. antibodies in systemic lupus erythematosus. Lancet. 1971 Oct 16;2(7729):861–863. doi: 10.1016/s0140-6736(71)90234-0. [DOI] [PubMed] [Google Scholar]
- Raftery E. B., Denman A. M. Systemic lupus erythematosus syndrome induced by practolol. Br Med J. 1973 May 26;2(5864):452–455. doi: 10.1136/bmj.2.5864.452. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rowland M. G., Stevenson C. J. Exfoliative dermatitis and practolol. Lancet. 1972 May 20;1(7760):1130–1130. doi: 10.1016/s0140-6736(72)91482-1. [DOI] [PubMed] [Google Scholar]
- Windsor W. O., Durrein F., Dyer N. H. Fibrinous peritonitis: a complication of practolol therapy. Br Med J. 1975 Apr 12;2(5962):68–68. doi: 10.1136/bmj.2.5962.68. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wright P. Untoward effects associated with practolol administration: oculomucocutaneous syndrome. Br Med J. 1975 Mar 15;1(5958):595–598. doi: 10.1136/bmj.1.5958.595. [DOI] [PMC free article] [PubMed] [Google Scholar]